TipRanks
Medicinova (JP:4875)
:4875
Japanese Market
4875
Medicinova
RESEARCH TOOLSreports

Medicinova (4875) Stock News & Sentiment

0 Followers
Buy Rating Reaffirmed on MediciNova as Advancing Pipeline and Upcoming Catalysts Support Unchanged $6 Price Target
Premium
Ratings
Buy Rating Reaffirmed on MediciNova as Advancing Pipeline and Upcoming Catalysts Support Unchanged $6 Price Target
2d ago
MNOV
Analyst Reiterates Buy on Medicinova, Maintaining $10 Price Target Amid Advancing ALS and Metabolic Disease Programs
Premium
Ratings
Analyst Reiterates Buy on Medicinova, Maintaining $10 Price Target Amid Advancing ALS and Metabolic Disease Programs
4d ago
MNOV
MediciNova Ends Standby Equity Financing Agreement
Premium
Company Announcements
MediciNova Ends Standby Equity Financing Agreement
26d ago
8K
MNOV
MediciNova Updates Executive Contracts, Enhancing Change-in-Control Protection
Premium
Company Announcements
MediciNova Updates Executive Contracts, Enhancing Change-in-Control Protection
1M ago
8K
MNOV
Jason McCarthy Reiterates Buy on MediciNova, Maintains $6 Price Target Ahead of Key ALS and Metabolic Disease Readouts
Premium
Ratings
Jason McCarthy Reiterates Buy on MediciNova, Maintains $6 Price Target Ahead of Key ALS and Metabolic Disease Readouts
1M ago
MNOV
Analyst Reiterates Buy on MediciNova with Unchanged $10 Price Target Amid Progress of Lead Clinical Programs
Premium
Ratings
Analyst Reiterates Buy on MediciNova with Unchanged $10 Price Target Amid Progress of Lead Clinical Programs
1M ago
MNOV
MediciNova: Differentiated NAFLD/MASH Profile and Complementary APOC3 Positioning Support Unchanged $6 Target and Buy Rating
Premium
Ratings
MediciNova: Differentiated NAFLD/MASH Profile and Complementary APOC3 Positioning Support Unchanged $6 Target and Buy Rating
2M ago
MNOV
More JP:4875 News >

4875 News on the Web

Buy Rating Reaffirmed on MediciNova as Advancing Pipeline and Upcoming Catalysts Support Unchanged $6 Price Target
TipRanks News
Bullish
MediciNova initiated with a Buy at Roth Capital
TipRanks News
Bullish
MediciNova Ends Standby Equity Financing Agreement
TipRanks News
Neutral
MediciNova Updates Executive Contracts, Enhancing Change-in-Control Protection
TipRanks News
Bullish
Jason McCarthy Reiterates Buy on MediciNova, Maintains $6 Price Target Ahead of Key ALS and Metabolic Disease Readouts
TipRanks News
Bullish
Analyst Reiterates Buy on MediciNova with Unchanged $10 Price Target Amid Progress of Lead Clinical Programs
TipRanks News
Bullish
Analyst Reiterates Buy on MediciNova as Advancing Pipeline and Upcoming ALS Catalysts Support Unchanged $6 Price Target
TipRanks News
Bullish
MediciNova Shareholders Reject Proposal to Increase Authorized Stock
TipRanks News
Neutral

News Score - Last 7 Days

Positive
JP:4875
Sector Average
Media Buzz
This Week3 articles
Weekly Average1.25 articles
News Sentiment
This Week100%
Sector Average91%
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is JP:4875’s Media Buzz Sentiment?
3 articles about JP:4875 were published this week. In an average week, 1.25 articles are published.
    What is JP:4875’s weekly average amount of articles?
    In an average week, 1.25 articles about JP:4875 are published.
      What is JP:4875’s News Sentiment?
      100% of articles about JP:4875 were positive this week, compared to its sector average of 91%.
        Healthcare Stocks that are Trending in the News
        LGNDLigand Pharma
        ABBVAbbVie
        ANABAnaptysBio
        CDNACareDx
        ARCTArcturus Therapeutics
        Showing the stocks with the most bullish news sentiment over the past week